Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial-Reference-Cited by-同舟云学术

Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial

Published:2015-05-22 Issue:2 Volume:38 Page:202-207
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Ghosh-Laskar Sarbani¹,Kalyani Nikhil¹,Gupta Tejpal¹,Budrukkar Ashwini¹,Murthy Vedang¹,Sengar Manju²,Chaukar Devendra³,Pai Prathamesh³,Chaturvedi Pankaj³,D'Cruz Anil³,Agarwal Jaiprakash¹

Affiliation:

1. Department of Radiation Oncology; Tata Memorial Hospital Centre; Parel Mumbai India

2. Department of Medical Oncology; Tata Memorial Hospital Centre; Parel Mumbai India

3. Department of Head and Neck Surgical Oncology; Tata Memorial Hospital Centre; Parel Mumbai India

Publisher

Wiley

Subject

Otorhinolaryngology

Reference14 articles.

1. MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

2. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis;Bourhis;Lancet,2006

3. Blanchard P Lacas B Bourhis J Meta-analysis of radiotherapy in head and neck carcinomas: an update. Presented at the European Cancer Congress 2013 (ECCO-ESMO-ESTRO); September 27-October 1, 2013

4. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial;Overgaard;Lancet,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial;Radiotherapy and Oncology;2024-08

2. Osteoradionecrosis Rates After Head and Neck Radiation Therapy: Beyond the Numbers;Practical Radiation Oncology;2024-07

3. Exploring Oral Cavity Cancer in the United Arab Emirates (UAE);Cureus;2024-02-02

4. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma;Cancer Control;2024-01

5. Indian clinical practice consensus guidelines for the management of oropharyngeal cancer: Update 2022;Cancer Research, Statistics, and Treatment;2024-01